NYSE · DOLE
Dole plc
$13.00-$0.15 (-1.14%)
Dole plc’s quoted price sits in the lower half of its reported 52-week range, 21.54% below the high.
Loading market information…
NASDAQ · TMDI · USD
Stock price, earnings
Quote as of Mar 9, 2023, 09:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Titan Medical Inc.’s quoted price sits in the lower half of its reported 52-week range, 88.33% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Titan Medical Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Titan Medical Inc. is a medical technology firm dedicated to developing and commercializing advanced robotic systems for use in minimally invasive surgical procedures. The company's flagship product currently under development is the Enos system, a pioneering robotic platform designed for single-port access surgery. This innovative system features a surgeon-operated patient cart, equipped with a high-definition 3D imaging system and adaptable, multi-articulated instruments for precise surgical execution. Furthermore, a specialized surgeon workstation provides an ergonomic control interface for the cart, offering a real-time, three-dimensional endoscopic view from within the patient's body throughout operations. Titan Medical Inc. maintains its corporate headquarters in Toronto, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| May 17, 2021 |
| -$0.15-50.0% vs estimate |
| $50.00K+21.21% vs estimate |
THE ANALYST VIEW
5 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$13.00-$0.15 (-1.14%)
Dole plc’s quoted price sits in the lower half of its reported 52-week range, 21.54% below the high.
$0.70-$0.00 (-0.16%)
Enzo Biochem, Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.27% below the high.
$2.21$0.00 (+0.46%)
QT Imaging Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.92% below the high.
$0.45$0.00 (0.0%)
Lucira Health, Inc.’s quoted price sits in the lower half of its reported 52-week range, 89.6% below the high.
$2.27+$0.01 (+0.44%)
Conformis, Inc.’s quoted price sits in the lower half of its reported 52-week range, 68.69% below the high.
$0.46+$0.00 (+0.22%)
Chembio Diagnostics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 63.31% below the high.
$2.67+$2.67 (+100.0%)
Psychemedics Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.57-$0.26 (-30.77%)
Kineta, Inc.’s quoted price sits in the lower half of its reported 52-week range, 89.34% below the high.
